Kristen Sanfilippo MD, MPHS

Kristen M. Sanfilippo, MD, MPHS, is an Associate Professor of Medicine at the Washington University School of Medicine in St. Louis. She earned a Master's in Population Health Sciences at Washington University, St. Louis School of Medicine in 2012. Since completion of her Master’s degree, Dr. Sanfilippo has focused her research on health outcomes in patients with venous thromboembolism with a focus on cancer-associated thrombosis.

Sanfilippo research group developed and validated a risk prediction model, IMPEDE VTE, to identify patients with multiple myeloma starting chemotherapy at high risk of venous thromboembolism. IMPEDE VTE is recommended as the risk prediction model of choice by the National Comprehensive Cancer Network (NCCN) clinical guidelines. Her clinical and research interests continue to focus on venous thromboembolism and cancer-associated thrombosis, with her current work focused on understanding risk factors for anticoagulant-related bleeding in patients with cancer.